SciELO - Scientific Electronic Library Online

 
vol.30 número3Análisis de medicamentos potencialmente inapropiados recetados a personas mayores pacientes en un entorno hospitalarioFactores para el desarrollo de la atención farmacéutica en farmacias comunitarias en Buenos Aires, Argentina, a través del modelo de ecuaciones estructurales mediante mínimos cuadrados parciales (PLS-SEM) índice de autoresíndice de materiabúsqueda de artículos
Home Pagelista alfabética de revistas  

Servicios Personalizados

Revista

Articulo

Indicadores

Links relacionados

  • En proceso de indezaciónCitado por Google
  • No hay articulos similaresSimilares en SciELO
  • En proceso de indezaciónSimilares en Google

Compartir


Revista de la OFIL

versión On-line ISSN 1699-714Xversión impresa ISSN 1131-9429

Resumen

VILLARREAL RIOS, E et al. Cost effectiveness of lispro protamine insulin (NPL) vs. combination of NPH insulin + rapid insulin. Rev. OFIL·ILAPHAR [online]. 2020, vol.30, n.3, pp.221-226.  Epub 05-Abr-2021. ISSN 1699-714X.  https://dx.doi.org/10.4321/s1699-714x2020000300012.

Objective:

Pharmacological strategies for the management of patients with type 2 diabetes include lispro protamine insulin (NPL) and NPH insulin + rapid insulin. The cost-effectiveness study addresses the economic and epidemiological aspects in the process of choosing between two or more alternatives. The objective is to determine the cost effectiveness of lispro protamine insulin (NPL) vs. combination of NPH insulin + rapid insulin.

Methods:

Cost effectiveness study in patients with type 2 diabetes. Alternative 1: lispro protamine insulin (NPL) and alternative 2: NPH insulin + rapid insulin. Sample size 62 per group, simple random sampling technique. Cost (estimated in Mexican pesos) included, unit cost, intensity of use of the service, average cost per input, average cost per service, and cost per type of alternative (including family medicine, laboratory and medication.) Effectiveness was determined with the average glucose results carried out throughout the year. Analysis plan included cost effectiveness analysis and incremental cost effectiveness analysis.

Results:

The total average cost of lispro protamine insulin (NPL) and NPH insulin + rapid insulin mixture was $6,146.30 and $2,671.02, respectively. The NPH insulin + rapid insulin mixture alternative has lower cost and greater effectiveness. According to the cost effectiveness analysis, with the NPH insulin + rapid insulin mixture alternative, there was a saving of $159.98 for each milligram of glucose per deciliter comparing to the lispro protamine insulin (NPL) alternative.

Conclusion:

According with our results, a better cost-effectiveness ratio was obtained in NPH insulin + rapid insulin.

Palabras clave : Diabetes mellitus type 2; insulin; treatment; cost effectiveness.

        · resumen en Español     · texto en Español     · Español ( pdf )